ASX
Argenica Therapeutics Limited
AGN:ASX•Healthcare
Sensitive ASX Announcement
Sentinel Subjects Dosed in Second Cohort of Phase 1 Trial
Published: 07/11/22, 08:21am (AEST)•1 pages